Gradalis is dedicated to developing and commercializing “molecular” based personalized therapeutics that are tumor specific, more effective and less toxic than current treatment modalities.

 

 

 
Published on Dec 18, 2013

Carley Rutledge is studying biology at university in Colorado. She loves hiking and hanging out with friends. Many of us take these things for granted, but for Carley they are only possible because she's taking part in a trial for a cancer vaccine. Without the trial, Carley would have been stuck in hospital having a second round of chemotherapy. Carley tells her story in this film. We also hear from her doctors, who are pioneering this new personalized cancer treatment that uses a patient's own immune system to fight the disease.